09.30am, CT - The last day of the 2021 digital summit will give the opportunity for attendees to participate in a networking session and visit the sponsor hubs to gain access to more industry information through downloadable PDFs.


10.00am, CT - Probiotics, Prebiotics and Immune Function

Introduction from our Chair of the Digital Summit, Stephen Daniells, Editor-in-Chief, NutraIngredients-USA

Paul Wischmeyer, MD, Professor of Anesthesiology and Surgery, Duke University School of Medicine
Paul's presentation will be on: Key Role of Probiotics in Prevention and Treatment of COVID-19 and Other Infections
Randomized clinical trials of probiotics have shown that prophylaxis with probiotic organisms may reduce lower respiratory tract infections, sepsis, and pneumonia by 30-50%. These benefits appear to be mediated by immune system modulation as our and other studies show probiotics can upregulate antiviral factors, increase clearance of infections from respiratory epithelium, increase regulatory T cells and decrease pro-inflammatory cytokines to attenuate inflammatory responses and disease severity.
These clinical and immunomodulatory benefits are relevant to individuals who have or are at risk of developing COVID-19. Clinical trials of probiotics to prevent or treat COVID-19 are ongoing to address probiotics as a safe, inexpensive, and commercially available for mass-distribution, ideal agent in COVID-19, other current infectious pathogens, and future pandemic diseases.


Key Takeaways: 
  • Industrialization, diet changes, and antibiotic use have led to disruption of the long-standing evolved human microbial ecosystem, called dysbiosis that appears to contribute to increased risk of disease and impaired response to infection, including COVID-19
  • Randomized clinical trials of probiotics have shown that prophylaxis with probiotic organisms may reduce lower respiratory tract infections, sepsis, and ventilator associated pneumonia by 30-50%.
  • Probiotic benefits appear to be mediated by immune system modulation as our and other murine studies have shown probiotics can upregulate antiviral factors, increase clearance of infections from respiratory epithelium, increase regulatory T cells and decrease pro-inflammatory cytokines to attenuate inflammatory responses and disease severity
  • Recent data indicates dysbiosis is a common unifying pathologic condition in populations at highest risk for severe COVID-19 (i.e. diabetes, obesity, older age). In support of this, recent initial data indicates a link between dysbiosis and increased COVID-19 risk and disease severity.
  • Clinical trials of probiotics to prevent or treat COVID-19 are ongoing to address the probiotics as a safe, inexpensive, and commercially available for mass-distribution, ideal agent in COVID-19, other current infectious pathogens, and future pandemic diseases.

Panel discussion, our chair Stephen Daniells, will be joined by:

The panel discussion will be followed by a presentation.
Chyn Boon Wong, PhD, Research Associate, Morinaga Milk Industry
Chyn Boon's presentation will be on: Pro and Paraprobiotics & Immune Function
With consumer demand for immunity-supporting products soaring, probiotics are a wildly popular ingredient. Meanwhile, paraprobiotics – heat-killed, non-viable probiotic bacteria – have emerged as another ingredient that gains traction in the food and beverage market. Not all pro-and paraprobiotics are created equal. Learning how specific strains act in support of a healthy immune system would facilitate the development of appealing food and supplement products in the immune health space.
Key takeaways:

  • Understand how pro-and paraprobiotic work to support the immune system.
  • Learn about the solid clinical evidence behind the specific strains of pro-and paraprobiotics on immune health.
  • Walk away with a roadmap to the biggest application opportunity for pro-and paraprobiotics in the immune health space.

Final Q&A – put your questions to our panelists and keynote speaker Paul Wischmeyer, MD .   
*There will be live chat, Q&A and polling throughout the session


12.00pm, CT - Networking - the opportunity to chat to other delegates, schedule one-on-one meetings, visit our sponsor hubs and view our Scientific Frontiers posters.


June 17 | 10am - 12pm CT

Speaker Company Spotlight